Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

International Nursing Organizations II

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...

Methods Of Healthcare Delivery System

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...

International Nursing Organizations I

International Nursing Organizations I

International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...

Introduction To Health Care Delivery System

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...

Primary Healthcare Services

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

Current Trends in Nursing I

Current Trends in Nursing I

Current trends in nursing include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome.

Kidney360·2023

Same author

Reduced metabolic flexibility is a predictor of weight gain among liver transplant recipients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2023

Same author

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.

Gastroenterology·2023

Same author

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023

Same author

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023

Same author

Noninvasive Assessment of Liver Fibrosis in NAFLD.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2023

Search research articles

Related Experiment Videos

NASH: A global health problem.

Arun J Sanyal¹

¹Department of Pharmacology and Molecular Pathology, Virginia Commonwealth University, Richmond, Virginia, USA.

Hepatology Research : the Official Journal of the Japan Society of Hepatology

|June 30, 2011

Summary

This summary is machine-generated.

Non-alcoholic fatty liver disease (NAFLD) affects a third of the US population and poses significant health risks. This condition can lead to serious complications like cardiovascular events, cancer, and cirrhosis, highlighting its global public health impact.

Related Experiment Videos

Area of Science:

Hepatology
Public Health
Genetics

Background:

Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition globally, affecting a significant portion of the population.
NAFLD is closely linked to metabolic syndrome, with factors like obesity, diabetes, and increasing age increasing the risk of developing non-alcoholic steatohepatitis (NASH).

Purpose of the Study:

To summarize the public health implications of NAFLD.
To outline the associated health risks and progression of the disease.

Main Methods:

Review of existing epidemiological data and clinical studies on NAFLD prevalence and outcomes.
Analysis of factors contributing to NAFLD progression and associated comorbidities.

Main Results:

NAFLD affects approximately one-third of the US population.
Individuals with NAFLD face increased risks of diabetes, cardiovascular events, certain cancers, and liver cirrhosis (15-20% progression).
The PNPLA3 gene mutation is associated with increased inflammation and fibrosis in NAFLD.
NASH-related cirrhosis increases the risk of hepatocellular carcinoma and decompensation.

Conclusions:

NAFLD is a major global public health concern due to its high prevalence and severe health consequences.
Early identification and management of NAFLD are crucial to mitigate risks of progression to cirrhosis, cardiovascular disease, and cancer.